Ventavia Research Group LLC is a clinical research site located in Dallas, Texas, United States 75231.
Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.
Ventavia Research Group LLC has participated in 2 clinical trials.
Therapeutic areas: Respiratory Tract Infection, SARS-CoV-2 Infection, COVID-19.
Sponsors: Pfizer, BioNTech SE.
Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Ventavia Research Group LLC has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Ventavia Research Group LLC has 2 clinical trials on record. Their work covers Respiratory Tract Infection, SARS-CoV-2 Infection, COVID-19.
Ventavia Research Group LLC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.